Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting
Titel:
Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting
Auteur:
Ludwig, Heinz Ramasamy, Karthik Mateos, María-Victoria Kishore, Bhuvan Gergely, Varga Ladicka, Miriam Ori, Alessandra Simoni, Lucia Bent-Ennakhil, Nawal Stull, Dawn Marie Gavini, François Terpos, Evangelos Hájek, Roman